P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

January 2007

Features

Medicare Update: Into the Doughnut Hole

Dr. Stefanacci explains the new rules for Medicare’s Part D drug benefit for the year 2007 and offers strategies for reducing out-of-pocket expenses for beneficiaries.
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Augmentation and Combination Pharmacotherapy Trends in Major Depressive Disorder: Results of a Brief Survey of Psychiatrists

The authors present the results of a brief audience participation survey of 601 psychiatrists about their practices of prescribing antidepressants and discuss the use of first-line, second-line, and third-line treatment options.
Thomas L. Schwartz, MD, and Ayesha Rashid, MD

Managing Hypertension in Patients with or without Comorbidities in a Teaching Hospital Outpatient Setting

Patients were able to achieve reductions of blood pressure, glycosylated hemoglobin, and low-density lipoprotein-cholesterol, according to the authors, because physicians adhered to national guidelines and spent “quality time” with these patients.
Shan Wang, PharmD, RPh, Nicholas Berbari, MD, David Choi, DO, James McNamara, PharmD Candidate, Martin Feuerman, MS, Kathryn Bucci, PharmD, and Brian Malone, MS, RPh

Meeting Highlights

Chemotherapy Foundation Symposium XXIV: Innovative Cancer Therapy for Tomorrow: Part 2

Dr. Goldenberg discusses the current status of targeted therapies for colorectal cancer; novel biologic agents that target angiogenesis and growth factors; a monoclonal antibody for colon and pancreatic cancer; and kinase-targeted drugs for gastrointestinal stromal tumors.
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

American Heart Association Scientific Sessions 2006

The authors review the cardiovascular risks of commonly used painkillers and present the latest findings on acute myocardial infarction, atrial fibrillation in hypertension, cardiovascular disease in diabetes patients, non–ST-segment elevation in acute coronary syndrome, and familial hypercholesterolemia. The controversial torcetrapib/atorvastatin (Lipitor) combination is also discussed.
Lawrence M. Prescott, PhD, and Sharon L. Prescott

Departments

Editorial

PNWER Power

David Nash, MD, MBA, describes the Pacific Northwest Economic Region (PNWER), an alliance of states and territories that offers publicly funded health insurance in Canada.
David Nash, MD, MBA

Medication Errors

Systems Thinking: Tapping into Staff Creativity to Unleash Innovation

Matthew Grissinger, RPh, FASCP, explains how “systems thinking” can be used to prevent errors like the tragic accident in 2001 that killed a young MRI patient.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

With New Commissioner Aboard, Congress and the FDA Will Emphasize Postmarketing Surveillance and Adverse Reactions

Stephen Barlas discusses the challenges that face the new FDA Commissioner and Congress in 2007, especially the need to strengthen the FDA’s MedWatch system and its reporting of adverse drug events.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest studies and information about FDA approvals, drug indications, and industry updates.

Drug Forecast

Varenicline (Chantix): A New Treatment Option for Smoking Cessation

The authors review varenicline (Chantix) for smoking cessation.
Marilena S. Antonopoulos, PharmD, and Christine M. Bercume, PharmD